On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.

For more than a decade, doctors and researchers have announced that a handful of people around the world have been cured of ...

It’s about preventing avoidable illness and death and improving public safety,” Monroe County Commissioner Jody Madeira said.

Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.

The BRILLIANT 011, a first-in-human clinical trial, was officially launched at the Desmond Tutu HIV Foundation (DTHF) ...

New cancer therapies are dramatically improving outcomes while personalized medicine approaches emerge.

Infectious Disease Diagnostics Market Size To Reach USD 63.26 Billion By 2035, Driven By Rapid Testing Adoption And Molecular ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the ...

Bristol Myers Squibb today announced they have teamed up with renowned goalkeeper and sports commentator Kasey Keller, who is publicly sharing his personal experience with non-Hodgkin lymphoma (NHL) ...

Six Indiana counties operate a syringe service program, often acting as a bridge to healthcare, overdose prevention education and addiction treatment. But the programs could end in July, when the law ...